金健米业(600127) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 1,518,962,312.66, representing a decrease of 10.11% compared to the same period last year[5] - The net profit attributable to shareholders was a loss of CNY 5,471,749.94, a decline of 149.62% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was a loss of CNY 8,521,555.78, down 209.10% compared to the previous year[5] - The basic earnings per share were CNY -0.0085, a decrease of 149.42% year-on-year[5] - The diluted earnings per share were also CNY -0.0085, reflecting the same decline as basic earnings[5] - The weighted average return on equity was -0.77%, a decrease of 2.25 percentage points compared to the previous year[5] - The main reason for the decline in profits was the continuous rise in raw material procurement costs and a decrease in product sales and revenue[10] - Net profit for Q1 2022 was a loss of ¥5,028,829.30, compared to a profit of ¥11,522,325.58 in Q1 2021, representing a significant decline[22] - Operating profit for Q1 2022 was a loss of ¥4,200,661.11, compared to a profit of ¥12,869,320.05 in Q1 2021[21] Cash Flow and Liquidity - The net cash flow from operating activities was CNY 81,073,279.77, an increase of 9,954.80% year-on-year[5] - Cash flow from operating activities for Q1 2022 was ¥81,073,279.77, a substantial increase from ¥806,314.32 in Q1 2021[25] - Cash inflow from operating activities was CNY 3,174,758.63 in Q1 2022, down from CNY 103,112,693.12 in Q1 2021, indicating a significant decline in cash generation capabilities[32] - The net cash flow from investment activities was 100,141,065.21 CNY, an increase from 47,561,399.62 CNY in the previous year[33] - The total cash and cash equivalents at the end of the period reached 193,108,819.79 CNY, up from 83,760,312.63 CNY year-over-year[33] - The company reported a net increase in cash and cash equivalents of 148,797,419.22 CNY, contrasting with a decrease of -115,586,205.76 CNY in the previous year[33] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,332,421,007.84, an increase of 9.76% from the end of the previous year[6] - The company's current assets reached RMB 1,625,683,412.85, up from RMB 1,411,106,769.26 year-over-year[16] - The total liabilities stood at RMB 1,563,310,937.30, compared to RMB 1,350,648,034.60 in the previous year, indicating an increase in leverage[18] - The total cash inflow from financing activities in Q1 2022 was ¥210,000,000.00, a decrease from ¥478,920,926.17 in Q1 2021[25] - Total liabilities increased to CNY 535,803,751.19 in Q1 2022, compared to CNY 477,911,607.45 in Q1 2021, representing an increase of approximately 12.09%[28] Shareholder Equity - The equity attributable to shareholders decreased by 0.76% to CNY 710,011,388.71 compared to the end of the previous year[6] - The total equity attributable to shareholders decreased to RMB 710,011,388.71 from RMB 715,483,138.65, showing a decline in shareholder value[18] - The company's total equity decreased to CNY 610,235,575.57 in Q1 2022 from CNY 616,407,751.10 in Q1 2021, a decline of about 1.11%[29] Inventory and Borrowings - The inventory decreased to RMB 916,748,602.36 from RMB 978,678,276.68, reflecting a reduction in stock levels[16] - The company's short-term borrowings increased to RMB 1,030,923,007.62 from RMB 949,939,079.27, indicating a rise in debt financing[17] - Short-term borrowings rose to CNY 380,475,694.45 in Q1 2022, up from CNY 320,294,414.75 in Q1 2021, reflecting a 18.83% increase[28] Research and Development - Research and development expenses for Q1 2022 were ¥2,909,832.73, slightly down from ¥3,048,714.92 in Q1 2021[21] - Research and development expenses for Q1 2022 were CNY 861,754.24, up from CNY 650,868.43 in Q1 2021, indicating a 32.29% increase in investment in innovation[29] Accounting and Reporting - The company did not apply the new accounting standards for the current year[34] - The financial report was announced by the board of directors on April 28, 2022[35]